Molecular regulation of androgen action in prostate cancer

Scott M Dehm1, Donald J Tindall

  • 1Department of Urology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

Insights

Androgens regulate prostate function and cancer growth. This review explores androgen-regulated genes and their role in prostate cancer development and resistance to androgen ablation therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Androgens are key regulators of prostate gland function and development.
  • Androgen ablation is a primary treatment for advanced prostate cancer.
  • The androgen receptor (AR) mediates androgen action through gene regulation.

Purpose of the Study:

  • To review the androgen-regulated gene expression program in prostate cancer.
  • To examine the role of newly identified androgen-regulated genes in prostate cancer progression.
  • To summarize research on gene deregulation in castration-resistant prostate cancer.

Main Methods:

  • Review of recent gene expression profiling studies.
  • Analysis of traditional single-gene characterization studies.
  • Synthesis of findings on androgen-regulated genes in normal and malignant prostate tissues.

Main Results:

  • Numerous androgen-regulated genes have been identified.
  • These genes are crucial mediators of androgen action in prostate tissues.
  • Understanding these genes is vital for comprehending prostate cancer development.

Conclusions:

  • Androgen-regulated genes significantly influence prostate cancer growth and survival.
  • Further research into these genes may reveal new therapeutic targets.
  • Investigating gene deregulation is essential for overcoming treatment resistance.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...